CS6 is a widely expressed colonization factor of enterotoxigenic Escherichia coli (ETEC). To date, CS6 has not been well characterized in its native state. Here, we purified CS6 for the first time from an ETEC clinical isolate. Purified CS6 was composed of two structural subunits, CssA and CssB, which were present in equal amounts and tightly linked through noncovalent, detergent-stable association. The CssA subunit was poorly immunogenic, whereas CssB was highly immunogenic. Although the predicted molecular mass of CssA is 15 kDa, the purified CssA has an effective molecular mass of 18.5 kDa due to fatty acid modification. When purified CS6 was screened for its ability to bind with different extracellular matrix proteins, fibronectin (Fn) was found to interact with CS6 as well as CssA in a dose-dependent and saturable manner. This interaction was inhibited both by a synthetic peptide corresponding to the C-terminal hydrophilic, surface-exposed region Enterotoxigenic Escherichia coli (ETEC) infection is the leading cause of infantile diarrhea in developing countries and an important etiologic agent for traveler's diarrhea. ETEC accounts for approximately 210 million diarrhea episodes and 380,000 deaths annually (35). Community-based studies conducted in developing countries with children younger than 5 years have shown that ETEC was the most frequently isolated enteropathogen (34, 35). As a cause of traveler's diarrhea, ETEC was found to be associated with 40 to 70% of the cases, with drastic outcome in terms of morbidity and economic consequences (34).
Enterotoxigenic Escherichia coli (ETEC) infection is the leading cause of infantile diarrhea in developing countries and an important etiologic agent for traveler's diarrhea. ETEC accounts for approximately 210 million diarrhea episodes and 380,000 deaths annually (35) . Community-based studies conducted in developing countries with children younger than 5 years have shown that ETEC was the most frequently isolated enteropathogen (34, 35) . As a cause of traveler's diarrhea, ETEC was found to be associated with 40 to 70% of the cases, with drastic outcome in terms of morbidity and economic consequences (34) .
In order to initiate pathogenesis, ETEC strains must adhere to the small intestine (14) . This event is mediated by several proteinaceous surface antigens, collectively known as colonization factor antigens (CFAs) (6) . To date, more than 25 distinct colonization factors have been identified, of which CS6 is the most prevalent in many countries (7, 20, 22) . Many of the colonization factors have morphology of fimbriae or pili (14) . However, the morphology of CS6 has not so far been defined. CS6 was assumed to be either a nonfimbrial or a short oligomeric assembly that does not protrude enough to be visualized under an electron microscope (17) . Functional CS6 is expressed and transported to the bacterial surface in a chaperone-usher pathway. CssC and CssD are the chaperone and usher proteins, respectively, that help surface expression of the CS6 structural subunits, CssA and CssB (33) .
The role of CS6 in intestinal adherence has been demonstrated using CS6-expressing whole bacteria, but the receptor specificity is still unknown (11) . A recent report has shown that when CssB is mutated, binding of bacteria to a colonic cell line (CaCo-2) is reduced slightly compared to that of the bacteria expressing whole CS6 (30) .
Here, we have purified CS6 to homogeneity from a clinical isolate of ETEC and separated its subunits (CssA and CssB) for the first time. We have characterized CS6 in its native form and demonstrated that fibronectin (Fn) is the interacting matrix for adherence. The carboxy-terminal (C-terminal) region of CssA plays a key role in this interaction with the aminoterminal (N-terminal) region of Fn.
MATERIALS AND METHODS
Bacterial isolate and growth conditions. ETEC isolate 4266 (serogroup O167, LT ϩ ) expressing CS6 as the only CFA (7) was used in this study. This strain was isolated from a patient with diarrhea undergoing treatment at the Infectious Diseases Hospital, Kolkata, India. For expression of CS6, the strain was grown overnight in CFA broth (1% Casamino Acids, 0.15% yeast extract, 0.05% MgSO 4 , 0.0005% MnCl 2 , pH 7.4) (3) and maintained at Ϫ70°C as a 15% glycerol stock. A single colony grown on MacConkey agar (Difco, Detroit, MI) plate at 37°C was subcultured in CFA medium for further studies.
Purification of CS6. CS6 was purified from the ETEC 4266 strain by chromatographic methods using a DuoFlow system (Bio-Rad, Hercules, CA). ETEC 4266 was grown overnight at 37°C in CFA broth, and heat-saline extract was prepared as described earlier (15) . Briefly, the bacterial cells were incubated in 0.8% NaCl at 60°C for 20 min with mild shaking (20 rpm) , and the supernatant was collected by centrifugation at 8,000 ϫ g for 20 min. The heat-saline extract was then subjected to ammonium sulfate precipitation, and the pellet from 40 to 60% ammonium sulfate saturation was dissolved in buffer A (20 mM Tris-HCl, pH 7.0). The protein sample (ϳ3 mg) was dialyzed overnight in the same buffer and loaded onto a 3-ml Q-Sepharose FF column (GE Healthcare, Uppsala, Sweden) previously equilibrated in buffer A. The protein bound to the anionexchange matrix was eluted with a linear NaCl gradient of 0 to 0.6 M NaCl at a flow rate of 1 ml/min. CS6, along with minor contaminating proteins, were eluted at approximately 0.4 M NaCl in buffer A. The fractions containing CS6 were pooled and dialyzed in buffer A overnight at 4°C. The dialyzed sample was concentrated on a 1-ml UNO Q1 column (Bio-Rad) by step elution to 0.6 M NaCl in buffer A. Peak fractions were loaded onto a Superdex 200 (GE Healthcare) gel filtration column (1 cm by 40 cm) previously equilibrated with 0.15 M NaCl in buffer A at a flow rate of 0.5 ml/min. The CS6-containing pooled fractions were again concentrated using the UNO Q1 column as described before. Purity was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) after each step. The identities of the purified proteins were confirmed by N-terminal protein sequencing. The protein concentration was determined with the Bradford protein estimation kit (Bio-Rad) in all cases. The absence of lipopolysaccharide in the final preparation was monitored by estimation of neutral sugar (2) .
Cloning and sequencing of CssA and CssB. Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA) from an overnight culture of ETEC grown in CFA broth at 37°C, and cDNA was prepared using a reverse transcription kit (Promega, Madison, WI) following manufacturer's protocol. For PCR amplification, primers were designed based on the available sequences in GenBank (accession numbers U04846 and U04844) (33) and were procured commercially (Isogen Biosciences, Germany). The primers used were CssA (forward) (5Ј-AG AACAGAAATAGCGACTAA-3Ј) and CssA (reverse) (5Ј-GTTTACATAGTA ACCAACC-3Ј) for CssA and CssB (forward) (5Ј-AGGAAACTGGCAATATA AAT-3Ј) and CssB (reverse) (5Ј-ATTGCTGTAAAATGATACAG-3Ј) for CssB. After initial denaturation of cDNA at 94°C for 3 min, annealing was performed at 52°C for 45 s and elongation was done at 72°C for 1 min. After 35 cycles, final elongation was performed for 15 min. CssA and CssB were cloned individually in pGEMT-Easy (Promega) and transformed in JM109 following the manufacturer's protocol. Positive colonies were selected by blue-white selection in IPTG (isopropyl-␤-D-thiogalactopyranoside)/X-Gal (5-bromo-4-chloro-3-indolyl-␤-Dgalactopyranoside) plates supplemented with ampicillin. From the correct clones, the respective plasmid was purified using the Wizard Plus DNA purification system (Promega). Using the plasmid as a template, CssA and CssB were sequenced with an automated DNA sequencer (ABI Prism 3200; Applied Biosystems, Foster City, CA) using the above-mentioned primers.
Expression and purification of recombinant CS6. For amplification of the whole CS6 operon, primers were designed based on the available sequences as mentioned above. Forward and reverse primers were 5Ј-AGCCAATGCTGTC TGTAA-3Ј and 5Ј-CTAACATTGTTTATTTACAACA-3Ј, respectively. After initial denaturation for 3 min, annealing was done at 52°C for 45 s and elongation was performed at 72°C for 10 min. After 30 cycles, final elongation was performed for 15 min. The fresh amplicon (4,569 bp) was cloned in pGMT-Easy TA cloning vector (Promega) and transformed into competent E. coli (JM109 cells). Positive colonies were selected by blue-white selection. The recombinant plasmid was isolated and electroporated into E. coli (HB101) for expression of CS6 by standard methods. The expression was monitored by growing the cells in CFA broth containing ampicillin overnight at 37°C. Expression was confirmed by Western blotting.
Recombinant CS6 was purified by immunoaffinity column chromatography following the protocol described previously (21) . Briefly, anti-CssA antibody was coupled to a HiTrap N-hydroxysuccinimide-activated Sepharose column (GE Healthcare) following the manufacturer's procedure. Heat-saline extract prepared from the E. coli HB101 expressing CS6 was dialyzed in buffer A and was applied onto the equilibrated column. Unbound proteins were removed by washing with 5 column volumes of phosphate-buffered saline (PBS) (pH 7.4). Bound material was eluted with 0.1 M glycine-HCl (pH 3) and immediately neutralized by one-third volume of 1 M Tris (pH 8.5). The purity of CS6 was visualized in SDS-PAGE, and its identity was confirmed by Western blotting with a specific antibody against CssA (7) by chemiluminescence following standard protocols (13) .
Semiquantitative reverse transcription-PCR (RT-PCR).
The cDNA as prepared earlier was used as the template for amplification of CssA and CssB using the respective primers as mentioned above. PCR was performed within the linear range of amplification. The amplicons were analyzed on a 1% agarose gel and following staining with ethidium bromide. The relative band intensities were calculated by densitometric analysis using a gel documentation system (UVP, Upland, CA). As an internal control, parC was amplified with forward primer 5Ј-TGTATGCGATGTCTGAACTG-3Ј and reverse primer 5Ј-CTCAATAGCA GCTCGGAATA-3Ј as described previously (4) . The linear range was calculated by performing the PCR for 15 to 45 cycles.
Differential scanning calorimetry and separation of the two subunits. The transition temperature of each of the subunits was determined by differential scanning calorimetry (N-DSC II, Calorimetry Sciences Corp, UT). Purified CS6 (0.99 g/l) dialyzed in phosphate buffer (pH 7.4) was heated from 25°C to 100°C at 1°C/min. The final dialysate was used as a blank. The identities of the peaks were confirmed by heating the sample at 70°C, which is between the characteristic temperatures of the peaks, and the subunits were analyzed by Western blotting using specific antibodies for CssA and CssB.
Purification of CssA and CssB. To purify CssB, the whole CS6 was heated at 68°C in a water bath for 30 min, followed by high-speed centrifugation (13,200 rpm for 5 min). The pellet was washed twice in water and dissolved in 8 M urea. CssB was refolded by stepwise slow dialysis to 20 mM Tris-HCl (pH 6.8) containing no urea. Contaminating traces of CssA were removed by ion-exchange chromatography using a 1-ml UNO Q1 column (Bio-Rad) by step elution with 0.4 M NaCl in buffer A. The refolding of CssB was monitored by comparing the fluorescence spectrum with that of the native protein. CssA was purified from the supernatant by repetitive heating at 72°C followed by centrifugation (10,000 ϫ g) for 10 min. This process was repeated until the CssB subunit was completely precipitated. Purity was checked by SDS-PAGE followed by silver staining.
Preparation of antibody. To raise antibody against each of the subunits, individual protein bands were sliced from SDS-12.5% polyacrylamide gels and crushed in PBS, and approximately 5 g of the CssA or CssB was injected into the peritoneal cavities of 6-week-old female BALB/c mice. After two subsequent booster doses, anti-CssA and anti-CssB sera were collected. To obtain antibody against whole CS6, purified CS6 mixed with Freund's complete adjuvant (Sigma, St. Louis, MO) was intraperitoneally injected into mice, followed by two booster doses of CS6 with incomplete adjuvant (Sigma). Antibody against the C-terminal peptide of CssA was prepared as described before (7).
Specificity of the antibody was determined by Western blotting. Briefly, an equal amount of pure CS6 was resolved in 15% SDS-PAGE, and the proteins from the gel were transferred to nitrocellulose membrane (Bio-Rad). To ensure equal loading, the membrane was stained with 0.2% Ponceau S (Sigma) in 0.1% glacial acetic acid. CssA and CssB were focused with the respective antibodies followed by alkaline phosphatase-conjugated secondary antibody. Bound antibody was visualized using nitroblue tetrazolium-BCIP (5-bromo-4-chloro-3-indolylphosphate) as the substrate, following described previously (24) .
The antibody titer was determined by enzyme-linked immunosorbent assay (ELISA). Briefly, 100 l of purified CssA and CssB (1 ng/l) were applied to an ELISA plate. Specific antibodies at different dilutions (1:50, 1:100, 1:500, 1:1,000, 1:2,000, 1:5,000, and 1:100,000 in PBS) were added and incubated for 2 h. After washing, each well was incubated with secondary antibody tagged with horseradish peroxidase (HRP) for 1 h, and the bound antibody was quantitated using o-phenylenediamine as a substrate. The absorbance at 492 nm was obtained by standard methods (24) . Preimmune serum was used as negative control.
Determination of molecular mass by ESI-MS. The electrospray ionizationmass spectrometry (ESI-MS) analysis was performed by using an API 2000 mass spectrometer (Applied Biosystems). Before analysis, the samples were dialyzed extensively in distilled water and finally brought into 50% acetonitrile with 0.1% acetic acid. The final concentrations of CssA and CssB were approximately 11 M. To determine the molecular mass, positive ESI spectra with m/z values ranging from 650 to 1,800 were studied, and the mass was determined by using Analyst 1.4.1 software (Applied Biosystems).
GLC analysis. Purified subunits (2 M each) were completely saponified with 0.5 N methalonic KOH separately. For determination of fatty acid composition by gas-liquid chromatography (GLC) (6890N; Agilent Technologies, Santa Clara, CA), methyl esters were prepared following standard methods (16) . Using a DB Wax column in a flame ionization detector, the fatty acid composition was analyzed. The percentage composition of component fatty acids was determined by measuring the areas under the peaks from the chromatogram. The fatty acid peaks were identified by comparison with standard methyl esters (Sigma).
Computational analysis. The primary sequences of both CssA and CssB were determined from the gene sequence. To design peptides for the binding studies, the sequence was analyzed with the PLOTSTRUCTURE program (Discovery Studio) (18) . Stretches of surface-exposed, hydrophilic regions were selected as probable binding regions of CS6.
Solid-phase binding assays. To demonstrate matrix adhesion, binding assays were performed with ETEC, pure CS6, and peptides. Ninety-six-well ELISA plates were coated with Fn, collagen IV, and laminin (Sigma), whenever necessary, as described earlier (27) . ETEC 4266 was biotinylated (25) as a tool for detection and incubated with immobilized Fn for 1 h to determine the adherence. Adhesion was quantitated by ELISA following standard protocols using HRP-conjugated avidin (Sigma). Increasing concentrations of purified CS6 (0 to 80 nM) were used in competition assays against the ETEC strain. The dissociation constant (K d ) for the CS6 binding was determined using increasing concentrations of CS6 (0 to 80 nM), and bound CS6 was determined with anti-CssB polyclonal antibodies (1:500 dilution) followed by HRP-conjugated secondary antibodies using a standard ELISA protocol. The dissociation constant for CS6 with Fn was determined by the equation obtained from the curve-fitting data:
where X is the molar concentration of CS6 determined. Binding of CS6 to Fn was competed with purified CssA and CssB (100 l from a 60-ng/l solution of each), and the bound CS6 was detected using anti-CS6 antibodies. To define the interacting domain of Fn, the N-terminal 30-kDa fibrin binding domain, 45-kDa gelatin binding domain, and 70-kDa domain were obtained commercially (Sigma). All the domains were dialyzed extensively in 20 mM Tris-HCl (pH 6.8), and equal molar concentrations (28.7 nM) of the Fn domains were applied to ELISA plates. Binding of CS6 with the respective domains was determined from fitted dose-response curves using increasing concentration of CS6 (0 to 550 nM) from the equation
where X, A1, A2, and A3 are the CS6 concentration, V max , association constant, and Hill coefficient, respectively. Intrinsic tryptophan fluorescence studies. For determination of the interaction between CssA and CssB, both subunits were dialyzed in buffer A, and CssB was titrated with CssA. CssB contained one tryptophan (at position 3 of the mature protein), but CssA had no tryptophan. When CssA was added to CssB, the binding of CssA caused quenching of the fluorescence intensity of CssB. The fluorescence measurements were performed at 25°C on a Hitachi F3010 spectrofluorimeter (Hitachi Ltd., Tokyo, Japan) using an excitation wavelength of 295 nm and recording emission at 340 nm. The excitation and emission band passes were 5 and 10 nm, respectively. The absorbance of the solution was Ͻ0.1 absorption unit/cm at the excitation wavelength, and the fluorescence intensity was corrected for dilution when ligand solution was added. For measuring the K d , we used the following equation (23) obtained from curve fitting:
In equation 3, F 0 and F are the fluorescence intensities of CssB at 340 nm in the absence and in the presence of CssA, respectively, at a given concentration, L T . F ratio and F ratio ϱ are the observed fluorescence ratios at any given concentration (L T ) and at the saturating ligand concentration, respectively. The end point of titration (F ratio ϱ ) is indicated by no further change in fluorescence intensity upon addition of more ligand, P 0 is the protein concentration, K d is the dissociation constant, n is the stoichiometry, and L T is the total ligand concentration. In order to determine the binding of CssA and the peptide quenching of tryptophan fluorescence, the intensity of Fn was measured. CssA or the peptides did not have any tryptophan, so purified CssA or the peptides were used for monitoring fluorescence quenching of Fn. Increasing concentration of CssA (3.43 M stock) and peptide A3 (Pep A3) (NYTSGDKEIPPGIYN) (3.12 mM stock) were added in aliquots separately to Fn (900 nM), and the K d was determined from the following equation (29) as obtained from the curve-fitting of the data:
where [L] 0 is the total concentration of ligand and ⌬F is the fluorescence intensity change observed at 340 nm.
where F E.L is the fluorescence intensity at 340 nm of the Fn-ligand complex and F E is the fluorescence intensity at 340 nm of Fn. Cell culture. Intestinal cell line INT 407 was grown to confluence in 12-well tissue culture plate in Dulbecco's modified Eagle's medium (Sigma) with 10% fetal bovine serum at 37°C with 5% CO 2 .
Confocal microscopy. CS6-expressing ETEC isolate 4266 was incubated with anti-CssA antibody (1:200) for 1 h and washed twice at 6,000 ϫ g at 4°C by centrifugation. Bacterial cells were incubated with anti-rabbit secondary antibody tagged with fluorescein isothiocyanate (FITC). Bacterial cells were washed for four times in PBS by centrifugation and visualized under a confocal microscope (LSM 510 Meta; Carl Zeiss, Germany) at a 520-nm emission wavelength and a magnification of ϫ40.
To study colocalization of CS6 and Fn, INT 407 cells grown on sterile coverslips were incubated with CS6 for 1 h. After incubation with CS6, cells were fixed with 2% paraformaldehyde in PBS (pH 7.2). The cells were incubated with anti-CssB antibody and focused with FITC-tagged secondary antibody. After being washed thrice, cells were further incubated with anti-Fn antibody, followed by secondary antibody tagged with R-phycoerythrin (Sigma, St. Louis, MO). After incubation for 1 h, cells were washed by dipping the coverslip in PBS thrice and mounted upside down with glycerol on a glass slide for visualization under a confocal microscope. To study colocalization, images were taken at emission wavelengths of 520 and 590 nm for FITC and R-phycoerythrin, respectively, and merged images were created.
Bacterial binding to the intestinal cell line. An overnight bacterial culture was harvested by centrifugation and resuspended in PBS. CS6-expressing ETEC (ϳ5 ϫ 10 6 CFU) were incubated with a confluent INT 407 monolayer, and the involvement of the CssA subunit in binding to Fn was compared by preincubating equal amounts of ETEC separately with Fn, anti-CssA (1:200), and anti-CssB (1:200) antibodies for 1 h. After 3 h of incubation, nonadherent bacteria were removed by washing the cells five times in PBS. Epithelial cells were then detached by treatment with trypsin-EDTA and plated on MacConkey agar (Difco, Detroit, MI) by serial dilution as described earlier (30) . The number of the colonies formed on MacConkey agar plates after overnight incubation at 37°C represented the viable bacterial cells that were bound to INT 407 cells. CS6 binding to Fn was calculated from the absorbance reading in ELISA. The K d was calculated from equation 1, obtained from the best-fitted curve. During binding of CS6 with proteolytic Fn fragments, the maximum absorbance reading was considered the saturation range. We found that the curve was nonlinear, so fitting was done to account for the cooperative binding, and equation 2 was obtained. In case of CssA-CssB interaction, the minimum quenching ratio was considered the saturation range. As we did not know the stoichiometry for interaction between CssA and CssB, we fitted the curve to obtain equation 3. For determination of the K d value, fitting parameters (for example, n and F ratio ϱ ) were varied systematically using the nonlinear least-squares fit procedure to obtain the best-fit curve. We found that an n value of 1 gave the best-fit curve. Binding of CssA or the peptide to Fn was calculated from fluorescence quenching. The maximum percentage of quenching was considered the saturation range. Fitting of the binding data for CssA and peptide with Fn was done, and equation 4 was obtained to determine the K d value.
Nucleotide sequence accession numbers. The CssA and CssB sequences of the ETEC 4266 isolate were deposited in GenBank under accession numbers EF451566 and EF451567, respectively.
RESULTS
Characterization of CssA and CssB of native CS6. To characterize CS6 in its native form, the protein was purified from a clinical ETEC isolate by using different chromatographic techniques. The two subunits, CssA and CssB, remained together during all purification steps (Fig. 1A) . Despite having differences in the net charge, the subunits could not be separated by ion-exchange chromatography in the presence of CssA was applied to a 96-well ELISA plate, and anti-CssA antibodies at different dilutions were added in different wells. Preimmune serum was used as a negative control. Each bar represents the mean Ϯ standard error of the mean from three independent experiments. Gray bars denote the antibody titer determined with anti-CssB antibody. White bars denote the antibody titer determined using antipeptide antibody. Black bars denote the antibody titer determined using anti-CS6 antibody. (C) Determination of anti-CssB antibody titer. Pure CssB was applied to a 96-well ELISA plate, and anti-CssB antibodies at different dilutions were added in different wells. Gray bars denote the antibody titer determined with anti-CssB antibody. Black bars denote the antibody titer determined using anti-CS6 antibody. Preimmune serum was used as a negative control. Bound antibody was determined using secondary antibody tagged with HRP. Each bar represents the mean Ϯ standard error of the mean from three independent experiments. (Fig.  1B) . The relative expression of cssA and cssB analyzed by semiquantitative RT-PCR suggested that equal amounts of transcript were made (Fig. 1C) , probably indicating equal production of both subunits.
To understand the thermal stability of CS6, differential scanning calorimetry was used. Purified CS6 gave two characteristic transitions at 70.94 and 75.41°C ( Fig. 2A) . SDS-PAGE analysis showed that when pure CS6 was incubated at 70°C, CssB was precipitated and CssA was left in solution, confirming the transition temperatures for CssB and CssA as 70.94°C and 75.41°C, respectively. Based on the transition temperatures, CssA and CssB were purified (see Materials and Methods for details). The derived amino acid sequence indicated that only CssB, and not CssA, had one tryptophan residue. Thus, the refolding of CssB was monitored by comparing the tryptophan fluorescence of the native CS6 (Fig. 2B) . Pure CssA was prepared by repeating the heating process several times (Fig. 2C) . To determine the K d for interaction between CssA and CssB, CssB was titrated with CssA. By quenching of the tryptophan fluorescence intensity of CssB, the K d was determined to be 3.2 ϫ 10 Ϫ12 M (Fig. 2D) , obtained from equation 3. The binding constant suggests that the interaction between the subunits was virtually irreversible. We found that the data were best fitted using an n value of 1 in equation 3 (n is the stoichiometry), and no significant improvement of the fit was observed when n was Ͼ1. This also suggested that CssA and CssB bound to each other at a probable stoichiometry of 1:1.
Studies of antibody response against CS6 subunits. To raise antibodies against CssA and CssB, the protein bands were crushed from SDS-polyacrylamide gels and injected into mice. Western blotting showed that anti-CssB antibody was produced but CssA antiserum was not produced. When CS6 con- taining both subunits was used for immunization, antiserum against CssB alone was obtained (Fig. 3A) . In contrast, when the C-terminal antigenic region was used for immunization in the form of a keyhole limpet hemocyanin-conjugated synthetic peptide (NYTSGDKEIPPGIYN), specific antibody against CssA was obtained, as described earlier (7). Antibody produced against CS6 or its individual subunits indicated that CssA was very poorly immunogenic. Next, ELISA was performed to analyze the titers of these antibodies (Fig. 3B and C) . Antibody raised against whole CS6 interacted with the CssA subunit at a dilution of 1:50 (Fig. 3B) . However, the same antibody interacted with CssB at a dilution of 1:1,000 (Fig. 3C) . The peptide antibody interacted with CssA at a dilution of 1:1,000, but antiserum raised against whole CssA showed almost no binding in ELISA.
The results further confirm that CssA is poorly immunogenic in mice. However, the presence of CssB could induce a poor immune response against CssA when they are injected together.
Molecular mass analysis of CS6 subunits. The molecular masses of pure CssA and CssB were estimated based on SDS-PAGE and MS (Table 1 ). In the MS, pure CssA gave two peaks, one at 18,459 Da and the other at 15,063 Da (Fig. 4A) . The molecular mass of 15,063 Da corresponded well with the theoretical molecular mass of the CssA subunit. The presence of the other peak at 18,459 Da raised the possibility of modification of CssA. In the case of CssB, however, the molecular mass that was determined by MS (15,924 Da) (Fig. 4B ) matched perfectly with its theoretical prediction ( Table 1) .
In order to identify the modification on CssA, GLC was performed. CssA modification was converted to methyl esters, and when the retention times for the peaks were compared with those for the known standards, palmitic, stearic, and oleic acids were identified (Fig. 4C) . The relative amounts of the fatty acids present, as calculated from the areas under the peaks, were 58.4, 28.7, and 12.9% for palmitic, stearic, and oleic acids, respectively. No such modification was observed on CssB (Fig. 4D) . When CS6 was treated with methanolic chloroform, the mobility of CssA did not change from that of untreated CssA as determined by Western blotting (Fig. 4E) . From the analysis, it was evident that the fatty acid modifications were covalently linked to CssA and were not artifacts.
CS6-expressing ETEC binds to immobilized Fn. To determine the probable binding substrate, different intestinal extracellular matrixes (Fn, laminin, and collagen IV) were tested for binding of CS6-expressing ETEC. Among these, Fn was found to be the probable binding matrix (Fig. 5A ). CS6-expressing ETEC bound to Fn in a CFU-dependent saturable manner (Fig. 5B) . The ETEC binding to Fn could be blocked by competition with purified CS6, suggesting its specific involvement in this interaction (Fig. 5C ). Purified CS6 also bound to immobilized Fn in a concentration-dependent, saturable manner (Fig. 5D) . The K d was determined as 77.28 Ϯ 8.5 nM from equation 1, suggesting that the binding was strong.
Identification of the CssA region that binds to Fn. In order to find out which subunit of CS6 played a role in Fn binding, a preincubation experiment was carried out. Preincubation of Fn with CssA inhibited binding of whole CS6 to this matrix by 24-fold (P Ͻ 0.05) (Fig. 6A) . However, preincubation of Fn with CssB did not affect the binding of CS6, suggesting the specific involvement of CssA in Fn binding. Direct evidence of CssA-Fn binding was obtained from quenching of the intrinsic fluorescence intensity of Fn on addition of pure CssA. CssA bound Fn in a concentration-dependent, saturable manner. The K d of interaction was 163 Ϯ 9.7 nM (Fig. 6B) , as determined using equation 4.
To define the interacting region(s) of the CssA subunit in Fn binding, surface-exposed, flexible regions of the subunits were selected, since they are the most probable regions for binding to a host receptor(s) ( Table 2) . Based on the analysis, three peptides corresponding to these identified regions were synthesized. The C-terminal region of CssA (residues 112 to 126) (NYTSGDKEIPPGIYN) blocked the binding of CS6 to Fn significantly (79% inhibition, P Ͻ 0.05) (Fig. 6C) . Binding of the peptide to Fn was in a concentration-dependent, saturable manner. The K d was 23 Ϯ 3.1 nM (Fig. 6D) as obtained from equation 4. To confirm whether the C-terminal region of CssA was indeed surface exposed in its native state, a confocal microscopic study was performed. Using the anti-CssA peptide antibody followed by FITC-tagged secondary antibody, live ETEC could be visualized under the microscope, suggesting that the binding region was exposed outwardly (Fig. 6E) .
Identification of the CS6 binding domain in Fn. To identify the interacting region of Fn involved in binding with CS6, three commercially available proteolytic fragments of human Fn were used. Among the three domains tested, the 70-kDa domain showed maximum interaction with CS6 (K d ϭ 63 Ϯ 5.8 nM), followed by the fibrin binding 30-kDa domain (K d ϭ 110 Ϯ 12 nM) and the gelatin binding 45-kDa domain (K d ϭ 251 Ϯ 31 nM) (Fig. 7A ). When competed with the Pep A3, binding of CS6 with the 70-kDa domain decreased in a concentrationdependent manner (Fig. 7B) , suggesting that the binding was specific.
Role of fatty acid modification in Fn binding. Western blot analysis showed that recombinant CssA expressed in E. coli HB101 had a higher mobility than the native CssA (Fig. 8A) , indicating that recombinant CssA might not have any fatty acid modifications. The molecular mass of recombinant CssA was found to be around 15 kDa in SDS-PAGE, which was similar to the theoretical calculated value based on the number of amino acids. Binding experiments using ELISA suggested that native CssA and recombinant CssA bound to Fn similarly (Fig. 8B) .
ETEC binding to INT 407cells. CS6-expressing ETEC was found to interact with INT 407 cells (Fig. 9A) . When purified Table 2 ). Each point is the mean Ϯ standard error of the mean from four independent experiments. (D) Quenching of tryptophan fluorescence emission spectra of Fn (900 nM) by incubation with Pep A3 (NYTSGDKEIPPGIYN) (3.12 mM stock). The binding constant was determined to be approximately 23 nM. A representative result is presented here. (E) Representative picture of ETEC, showing that the peptide region is surface exposed. Live bacteria were stained by incubation with anti-CssA antibody followed by FITC-labeled secondary antibody, mounted on a glass slide, and visualized under a confocal microscope at a magnification of ϫ40. To understand whether pure CS6 and Fn produced by INT 407 cells colocalize, confocal microscopy was performed (Fig.  9B) . Fn, as detected by anti-Fn antibody followed by phycoerythrin-tagged secondary antibody (red fluorescence), was localized along the INT 407 cell junctions. Purified CS6, detected by anti-CssB antibody followed by anti-FITC tagged secondary antibody (green fluorescence), was also found to be localized along the same region. When images were superimposed, a fusion color occurred that suggested specific interaction between these two proteins. The results thus revealed that CS6 binds specially to Fn along the cell junctions of INT 407 cells and colocalizes.
DISCUSSION
ETEC expresses an array of colonization factors that enables it to colonize the host intestine and cause diarrhea. Although CS6 is one of the most prevalent CFAs, it has not been characterized in detail in terms of structure-function relationships. In this study, we have purified CS6 in its native form from a clinical isolate of ETEC for the first time, characterized it, and elucidated the binding of CS6 with Fn.
During the purification steps, both subunits remained together, behaving like a structural unit. Neither of the subunits has cysteine, so there is no possibility of forming a disulfide linkage between them, suggesting that the interaction between the subunits is noncovalent in nature. Such a strong noncovalent association between two proteins is not common, but it exists in biological systems. The interaction between avidin and biotin, for example, shows association in the femtomolar range (8) . The presence of equal amounts of the two subunits in Coomassie blue-stained SDS-polyacrylamide gels suggested that CssA and CssB may be present in equal stoichiometry. The relative expression of the subunits in RT-PCR confirmed equal production of the transcripts at the RNA level. The studies of binding between CssA and CssB also suggested that the stoichiometry of the subunits is 1:1. Previously, it was suggested that the stoichiometry might be 3:1 based on relative signal intensities from the N-terminal protein sequencing data (33) . However, it was also suggested in the same report that the stoichiometry might be 1:1, and our results support the same. This 1:1 stoichiometry is more probable, as the CS6 operon has a region of dyad symmetry at 6 bp downstream of CssB, and this region essentially acts as a transcription terminator ensuring equal production of both of the subunits (33). The predicted molecular weight of CssB was little higher than that of CssA, but contrary to the theoretical prediction, CssB migrated faster in SDS-PAGE. MS suggested that CssA had modifications, which accounts for the anomalous migration in SDS-PAGE. GLC results confirmed these modifications in the CssA as palmitic, stearic, and oleic acids. During MS analysis, a portion of these fatty acids on CssA might have undergone aerial oxidation at the source during ionization, giving rise to two species of CssA (modified and unmodified). This modification was covalently attached, since treatment with methanolic chloroform could not remove the fatty acids, ruling out the possibility of any noncovalently attached artifact. In bacterial systems, such fatty acid modification is not an uncommon phenomenon. For example, hemolysin of E. coli (28) and the Fn binding protein BBK32 of Borrelia burgdorferi (26) are known to have lipid modifications that help in membrane anchoring. The precise role of the lipid modification on CssA is not yet clear.
Purified CssA is poorly immunogenic in mice, but antibodies at very low titers could be obtained in the presence of CssB. However, antibody could be raised against a synthetic unmodified peptide of CssA. Recently, it has been shown that antibody could be raised against a recombinant CssA in mice (30) . Since posttranslational lipid modifications may be the only differentiating factor between native CS6 of a clinical isolate of ETEC and the recombinant CssA was produced in engineered host, we may speculate that fatty acid modifications on CssA impair immunogenicity. Though native CssA alone does not produce antibody, it elicits the production of antibody in mice when present along with CssB, but at a very low titer.
Previous reports have indicated that several gram-positive and gram-negative bacteria bind to Fn (19, 26) . ETEC strain B34289c, isolated from an infantile diarrhea patient, was found to bind Fn. A 17-kDa protein representing a curlin, along with 55-kDa and 29-kDa surface proteins, were presumed to be involved in this interaction with Fn (5, 31). However, no specific receptor for CS6 has been identified to date. Here, we have clearly demonstrated for the first time that CS6 binds to Fn. Our results suggest that CssA is involved in interaction with Fn. In a very recent report, it has been shown that an E. coli strain expressing recombinant CS6 binds to colonic cell line CaCo-2 through CssB (30). Our results could not highlight a similar function of CssB. The apparent discrepancy in the observations may be due to the difference in cell lines and the use of laboratory E. coli expressing recombinant CS6 instead of pure protein.
In the present study, we have shown that pure CS6 binds to Fn of INT 407 intestinal cells. The C-terminal region of CssA mediates the interaction. The low dissociation constant of this interaction indicated that the binding is strong and specific. We have found that CS6 binds to both the N-terminal 29-kDa and 45-kDa domains of Fn. Together, both domains (which form the 70-kDa domain) bind to CS6 strongly. It may be possible that the binding motif of Fn for CS6 may be overlap between ETEC is mainly a noninvasive pathogen. However, there are reports that intestinal cell membrane asymmetry is altered during ETEC infection (13) . The presence of fecal leukocytes (10) and interleukin-8 (9) in stool samples from ETEC-infected patients has been observed. We have also observed an eightfold increase in interleukin-8 secretion upon incubation with CS6 in intestinal cell lines, indicating that CS6 might induce inflammation (unpublished observation). Fn is found to be distributed along the cell junctions, mainly along the basal and lateral sides. A study has demonstrated that more Fn relocates to the apical sides in polarized cells following inflammation (12, 32) . Thus, we hypothesize that after initial adherence of ETEC through CS6, more Fn is translocated from the basal and lateral parts to the apical sides of the cells, providing more binding sites to ETEC for pathogenesis.
In conclusion, we report for the first time the purification and characterization of native CS6. Since ETEC infection is widely prevalent, knowledge about the binding region in terms of receptor specificities will help in the future to develop a subunit vaccine against ETEC, saving millions of lives in developing countries.
